Literature DB >> 14556983

Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung.

Katalin Burián1, Hargita Hegyesi, Edit Buzás, Valéria Endrész, Zoltán Kis, András Falus, Eva Gönczöl.   

Abstract

Chlamydophila (Chlamydia) pneumoniae (C. pneumoniae) is the third most common cause of community-acquired pneumonia and is probably involved in the development of certain chronic inflammatory diseases, including atherosclerosis and adult-onset asthma. Histamine, synthesized by histidine decarboxylase (HDC) from L-histidine, plays an essential role in allergic and inflammatory processes and in cell differentiation. The effect of C. pneumoniae infection on the expression of HDC has not been examined. In the present study, normal Balb/c mice and HDC knockouts, and control mice with a CD1 background were infected intranasally with C. pneumoniae. On days 1, 3, 7, 16 and 31 after infection, the normal Balb/c mice were sacrificed and divided into three groups. In the homogenized lungs of the first group, C. pneumoniae titres were determined and demonstrated peak levels on day 7. HDC production was revealed by a Western blot assay throughout the observation period of 1-16 days, and cytokine concentrations were determined by ELISA. The interleukin-3 (IL-3) and interleukin-6 (IL-6) levels were highest on day 1 and on days 1-3, respectively; the interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) levels reached the maximum on day 7, but the quantity of IL-4 was still three times higher than that in the control group 16 days after infection. The lungs of the mice in the second group were processed for the in situ demonstration of HDC activity, while the lungs in the third group were stained for C. pneumoniae antigen. The HDC activity was increased predominantly in the bronchial epithelial cells, while C. pneumoniae antigens were expressed especially in the interstitial macrophages. The HDC knockout mice exhibited a higher survival rate after C. pneumoniae infection than did the control mice. These results point to a strong association between local histamine production and other inflammatory mediators and are novel in demonstrating the role of histamine in the pathomechanism of C. pneumoniae infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556983     DOI: 10.1016/s0165-2478(03)00154-8

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  13 in total

1.  Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.

Authors:  Anita Bogdanov; Valeria Endrész; Szabolcs Urbán; Ildikó Lantos; Judit Deák; Katalin Burián; Kamil Önder; Ferhan Ayaydin; Péter Balázs; Dezso P Virok
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

2.  Transcriptome analysis indicates an enhanced activation of adaptive and innate immunity by chlamydia-infected murine epithelial cells treated with interferon γ.

Authors:  Katalin Burian; Valeria Endresz; Judit Deak; Zsolt Kormanyos; Attila Pal; David Nelson; Dezso P Virok
Journal:  J Infect Dis       Date:  2010-11-01       Impact factor: 5.226

3.  Chlamydophila pneumoniae re-infection triggers the production of IL-17A and IL-17E, important regulators of airway inflammation.

Authors:  Tímea Mosolygó; József Korcsik; Emese Petra Balogh; Ildikó Faludi; Dezső P Virók; Valéria Endrész; Katalin Burián
Journal:  Inflamm Res       Date:  2013-02-06       Impact factor: 4.575

4.  Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study.

Authors:  Evagelia C Laiakis; Gerard A J Morris; Albert J Fornace; Stephen R C Howie
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

5.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

6.  Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues.

Authors:  Dezső P Virok; Tímea Raffai; Dávid Kókai; Dóra Paróczai; Anita Bogdanov; Gábor Veres; László Vécsei; Szilárd Poliska; László Tiszlavicz; Ferenc Somogyvári; Valéria Endrész; Katalin Burián
Journal:  Front Cell Infect Microbiol       Date:  2019-06-12       Impact factor: 5.293

7.  Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice.

Authors:  Francesco Blasi; Stefano Aliberti; Luigi Allegra; Gioia Piatti; Paolo Tarsia; Jacobus M Ossewaarde; Vivienne Verweij; Frans P Nijkamp; Gert Folkerts
Journal:  Respir Res       Date:  2007-11-19

8.  Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.

Authors:  Min Xia; Daxin Chen; Valeria Endresz; Ildiko Faludi; Andrea Szabo; Eva Gonczol; Vijay Kakkar; Xinjie Lu
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

9.  Bioactive Compounds of Nigella Sativa Essential Oil as Antibacterial Agents against Chlamydia Trachomatis D.

Authors:  Tímea Mosolygó; Ahmad Mouwakeh; Munira Hussein Ali; Annamária Kincses; Csilla Mohácsi-Farkas; Gabriella Kiskó; Gabriella Spengler
Journal:  Microorganisms       Date:  2019-09-19

10.  Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Authors:  Ildikó Lantos; Valéria Endrész; Dezső Péter Virok; Andrea Szabó; Xinjie Lu; Tímea Mosolygó; Katalin Burián
Journal:  Biomed Res Int       Date:  2018-03-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.